Insider · CIK 0001814653
Steven Kornfeld
Files at FBRX (Forte Biosciences, Inc.). First filing -, latest -.
Steven Kornfeld files SEC Form 4 as director at FBRX (Forte Biosciences, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Steven Kornfeld has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 29, 2026 | FBRX Forte Biosciences, Inc. | AGrant or award Restricted Stock Unitsderivative | +18,353 | $0.00 | $0 | 18,353 | Jun 2, 2026 |
| Mar 20, 2025 | FBRX Forte Biosciences, Inc. | AGrant or award Stock Option (right to buy)derivative | +31,000 | $0.00 | $0 | 31,000 | Mar 21, 2025 |
Questions about Steven Kornfeld
Answered from the filings on this page, as of the latest one.
Is Steven Kornfeld buying or selling?
Steven Kornfeld has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Steven Kornfeld's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Steven Kornfeld has 0.
Where does Steven Kornfeld file Form 4?
Steven Kornfeld has filed Form 4 at FBRX (Forte Biosciences, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.